approval
saveCABENUVA KIT (CABOTEGRAVIR) — FDA approval
March 23, 2022updated 6mo ago
community read0 votes
Sponsor: VIIV HLTHCARE. Form: SUSPENSION, EXTENDED RELEASE. Route: INTRAMUSCULAR
view source ↗Data sources
last refreshed 6mo ago
Found something off?
same company · ±60 days · 6
- approvalCABENUVA KIT (CABOTEGRAVIR) — FDA approvalMar 29, 2022
- approvalCABENUVA KIT (CABOTEGRAVIR) — FDA approvalMar 29, 2022
- approvalTRIUMEQ (ABACAVIR SULFATE) — FDA approvalMar 30, 2022
- approvalTRIUMEQ PD (ABACAVIR SULFATE) — FDA approvalMar 30, 2022
- approvalCABENUVA KIT (CABOTEGRAVIR) — FDA approvalFeb 7, 2022
- approvalCABENUVA KIT (CABOTEGRAVIR) — FDA approvalJan 31, 2022
comments(0)
5-min edit window · permanent after that